Compare CRWS & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRWS | LSTA |
|---|---|---|
| Founded | 1957 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Textiles | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.4M | 28.9M |
| IPO Year | 1994 | 2000 |
| Metric | CRWS | LSTA |
|---|---|---|
| Price | $2.98 | $3.56 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | ★ 49.4K | 26.3K |
| Earning Date | 02-11-2026 | 05-11-2026 |
| Dividend Yield | ★ 11.49% | N/A |
| EPS Growth | ★ 118.89 | 20.42 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $70,270,000.00 | $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.50 | ★ N/A |
| Revenue Growth | 6.51 | ★ 56.90 |
| 52 Week Low | $2.35 | $1.81 |
| 52 Week High | $3.17 | $5.07 |
| Indicator | CRWS | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | 56.01 | 55.32 |
| Support Level | $2.69 | $3.06 |
| Resistance Level | $3.11 | $3.67 |
| Average True Range (ATR) | 0.10 | 0.14 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 56.60 | 50.72 |
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.